Medical Science Liaison
BridgeBio
Medical Science Liaison
BridgeBio
Develops therapies for genetic diseases
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
You will report to the Senior Medical Director, EU Center and work closely with other MSLs, local Market Access, and regional and global Medical Affairs to execute our Medical Affairs brand plan and related strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers.
Your primary purpose will be to build and manage our KOL and HCP base in the pre-launch and launch phase, as BridgeBio engages with most customers in Germany for the first time. You will work on our initiatives during early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, engage with HCPs to increase diagnosis rates and support market access related work as a key stakeholder.
This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech company for the first time to KOLs, medical and scientific engagement and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition. We look for strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.
Rewarding Those Who Make the Mission Possible
As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
For BridgeBio Full-Time U.S Based Roles:
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
By applying, you acknowledge that BridgeBio will process your personal information as described in ourGlobal Candidate Privacy Notice.
BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.
Explore more opportunities at BridgeBio